Treatment of autoimmune diseases with antagonists which bind...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 37/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2372603

The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.

L'invention concerne le traitement de maladies auto-immunes au moyen d'antagonistes qui se fixent aux marqueurs de surface de lymphocytes B, tels que CD19 ou CD20.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of autoimmune diseases with antagonists which bind... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of autoimmune diseases with antagonists which bind..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of autoimmune diseases with antagonists which bind... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1588315

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.